Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Current Leases (2022 - 2025)

Mangoceuticals' Current Leases history spans 4 years, with the latest figure at $307823.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 373.85% to $307823.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $307823.0, a 373.85% increase, with the full-year FY2025 number at $307823.0, up 373.85% from a year prior.
  • Current Leases hit $307823.0 in Q4 2025 for Mangoceuticals, up from $12167.0 in the prior quarter.
  • Over the last five years, Current Leases for MGRX hit a ceiling of $307823.0 in Q4 2025 and a floor of $12167.0 in Q3 2025.
  • Historically, Current Leases has averaged $74310.6 across 4 years, with a median of $61917.0 in 2023.
  • The widest YoY moves for Current Leases: up 373.85% in 2025, down 82.45% in 2025.
  • Tracing MGRX's Current Leases over 4 years: stood at $56725.0 in 2022, then increased by 12.33% to $63718.0 in 2023, then grew by 1.95% to $64962.0 in 2024, then skyrocketed by 373.85% to $307823.0 in 2025.
  • Business Quant data shows Current Leases for MGRX at $307823.0 in Q4 2025, $12167.0 in Q3 2025, and $30117.0 in Q2 2025.